BIOGEN PHARMACHEM INDUSTRIES L (BIOGEN.BO)

INR 0.89

(0.0%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 23.81 Million 9.12 Million 21.68 Million 144.69 Thousand -2500.00 9.49 Million
Cost of Revenue 2.61 Million 1.13 Million 20.55 Million 14.8 Million 781.56 Thousand 9.1 Million
Gross Profit 21.19 Million 7.99 Million 1.13 Million -14.66 Million -784.06 Thousand 399 Thousand
Operating Expenses 4.5 Million 3.43 Million 1.21 Million 1.37 Million 382.9 Thousand 434 Thousand
Selling, General and Administrative Expenses 0.81 0.50 - -110.80 466.79 -
Research and Development Expenses 0.81 0.50 - -110.80 466.79 -
Other Expenses - -1000.00 -1806.00 -467.00 2.00 -478.00
Cost and Expenses 4.5 Million 4.57 Million 21.77 Million 16.17 Million 1.16 Million 9.53 Million
Operating Income 19.3 Million 4.55 Million -84.13 Thousand -16.03 Million -1.16 Million -35 Thousand
Interest Expense - 1000.00 1799.00 468.00 - 478.00
Income Tax Expense 19.3 Million 4.55 Million -84.13 Thousand -16.03 Million -1.16 Million -35 Thousand
Earnings before Tax 19.3 Million 4.55 Million -85.93 Thousand -16.03 Million -1.16 Million -35.47 Thousand
Net Income 19.3 Million 4.55 Million -85.93 Thousand -16.03 Million -1.16 Million -35.47 Thousand
Earnings Per Share Basic 0.03 0.01 -0.00 -0.02 -0.00 -0.00
Earnings Per Share Diluted 0.03 0.01 -0.00 -0.02 -0.00 -0.00
Weighted Average Shares Outstanding 652.6 Million 652.6 Million 652.6 Million 652.6 Million 652.6 Million 652.6 Million
Weighted Average Shares Outstanding (Diluted) 652.6 Million 652.6 Million 652.6 Million 652.6 Million 652.6 Million 652.6 Million
Gross Margin 0.89 0.88 0.05 -101.33 313.63 0.04
EBIT Margin 0.81 0.50 -0.00 -110.80 466.79 -0.00
Profit Margin 0.81 0.50 -0.00 -110.80 466.79 -0.00
EBITDA 19.3 Million 4.55 Million -84.13 Thousand -16.03 Million -1.16 Million -35 Thousand
Earnings Before Tax Margin 0.81 0.50 -0.00 -110.80 466.79 -0.00

Income Statement Charts